The clinical trials company checks in at number eight on the list of 100.
Small and nimble, clinical trials company 4G Clinical moves quickly to leverage technology to expedite medication for FDA approval. When the coronavirus hit, the team pivoted to focus on delivering drugs to step up clinical trials. “Starting in mid-March, we have been at the forefront of getting trials directly to people’s homes,” says founder and CEO David Kelleher. “When COVID-19 hit, we acted fast.”
Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company